ATE423770T1 - Benzoyltetrahydropyridine als glyt-1-inhibitoren - Google Patents
Benzoyltetrahydropyridine als glyt-1-inhibitorenInfo
- Publication number
- ATE423770T1 ATE423770T1 AT05820269T AT05820269T ATE423770T1 AT E423770 T1 ATE423770 T1 AT E423770T1 AT 05820269 T AT05820269 T AT 05820269T AT 05820269 T AT05820269 T AT 05820269T AT E423770 T1 ATE423770 T1 AT E423770T1
- Authority
- AT
- Austria
- Prior art keywords
- benzoyltetrahydropyridines
- glyt
- inhibitors
- Prior art date
Links
- 239000003112 inhibitor Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D211/70—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/444—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring heteroatom, e.g. amrinone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
- A61K31/5377—1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Psychiatry (AREA)
- Epidemiology (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP05100027 | 2005-01-04 |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE423770T1 true ATE423770T1 (de) | 2009-03-15 |
Family
ID=36118130
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT05820269T ATE423770T1 (de) | 2005-01-04 | 2005-12-27 | Benzoyltetrahydropyridine als glyt-1-inhibitoren |
Country Status (19)
Country | Link |
---|---|
US (1) | US7485637B2 (de) |
EP (1) | EP1836168B1 (de) |
JP (1) | JP4738421B2 (de) |
KR (1) | KR100957280B1 (de) |
CN (1) | CN101111477B (de) |
AR (1) | AR052553A1 (de) |
AT (1) | ATE423770T1 (de) |
AU (1) | AU2005324109B2 (de) |
BR (1) | BRPI0519746A2 (de) |
CA (1) | CA2594260A1 (de) |
DE (1) | DE602005012997D1 (de) |
ES (1) | ES2319220T3 (de) |
IL (1) | IL184206A (de) |
MX (1) | MX2007008043A (de) |
NO (1) | NO20073275L (de) |
RU (1) | RU2007124546A (de) |
TW (1) | TW200635898A (de) |
WO (1) | WO2006072432A1 (de) |
ZA (1) | ZA200705383B (de) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2653355C (en) * | 2006-06-22 | 2014-04-15 | F. Hoffmann-La Roche Ag | Substituted phenyl methanone derivatives |
JP6034215B2 (ja) * | 2013-02-19 | 2016-11-30 | 株式会社東芝 | 紙葉類処理装置 |
Family Cites Families (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2423847A1 (de) | 1973-05-28 | 1975-01-02 | Ciba Geigy Ag | Neue sulfamoylbenzoesaeureamide |
DE2533604A1 (de) | 1975-07-26 | 1977-02-10 | Bayer Ag | 2-substituierte 5-trifluormethyl1,3,4-thiadiazole, verfahren zu ihrer herstellung sowie ihre verwendung als fungizide und insektizide |
DE2611705A1 (de) | 1976-03-18 | 1977-09-22 | Josef Dipl Chem Dr Rer N Klosa | N-5-(nitrofurfuryliden-)-1-amino- hydantoin enthaltende kristalloesungsmittel |
US4122083A (en) | 1978-01-16 | 1978-10-24 | E. R. Squibb & Sons, Inc. | 1,2,3,4-Tetrahydropyrido[4',3':4.5]thiazolo-[3,2-a]benzimidazoles |
US4436002A (en) | 1981-12-11 | 1984-03-13 | Hughes Tool Company | Reversal mechanism for power tong |
IT1176613B (it) | 1984-08-14 | 1987-08-18 | Ravizza Spa | Derivati piperazinici farmacologicamente attivi e processo per la loro preparazione |
RU2124511C1 (ru) | 1993-05-14 | 1999-01-10 | Фармасьютикал Ко., Лтд | Производные пиперазина |
TW498067B (en) * | 1996-07-19 | 2002-08-11 | Hoffmann La Roche | 4-hydroxy-piperidine derivatives |
EP1059922A2 (de) | 1998-03-06 | 2000-12-20 | Janssen Pharmaceutica N.V. | Hemmer des glycintransports |
TR200002570T2 (tr) | 1998-03-06 | 2000-12-21 | Janssen Pharmaceutica N.V. | Glisin naklini önleyiciler |
US20030216385A1 (en) * | 2000-05-19 | 2003-11-20 | Takahiko Tobe | Triazole derivatives |
GB0021419D0 (en) | 2000-08-31 | 2000-10-18 | Oxford Glycosciences Uk Ltd | Compounds |
GB0106661D0 (en) | 2001-03-16 | 2001-05-09 | Pfizer Ltd | Pharmaceutically active compounds |
DE60234453D1 (de) | 2001-07-02 | 2009-12-31 | High Point Pharmaceuticals Llc | Substituierte piperazin- und diazepanderivate zur verwendung als histamin h3 rezeptormodulatoren |
WO2003035602A1 (fr) | 2001-10-25 | 2003-05-01 | Sankyo Company, Limited | Modulateurs lipidiques |
CA2467118A1 (en) * | 2001-12-20 | 2003-07-03 | H. Lundbeck A/S | Aryloxyphenyl and arylsulfanylphenyl derivatives |
US20060052597A1 (en) | 2002-10-22 | 2006-03-09 | Best Desmond J | Aryloxyalkylamine derivatives as h3 receptor ligands |
CN100372838C (zh) | 2003-02-17 | 2008-03-05 | 弗·哈夫曼-拉罗切有限公司 | 哌啶-苯磺酰胺衍生物 |
ME00116B (me) | 2003-08-11 | 2010-10-10 | Hoffmann La Roche | Piperazin sa ili supstituisanom fenil grupom i njihova upotreba kao inhibitora glyt1 |
KR100774621B1 (ko) | 2003-09-09 | 2007-11-14 | 에프. 호프만-라 로슈 아게 | 정신병 치료용의 글라이신 섭취 억제제로서의1-벤조일-피페라진 유도체 |
JP4563386B2 (ja) | 2003-09-09 | 2010-10-13 | エフ.ホフマン−ラ ロシュ アーゲー | 精神病の処置のためのグリシン取り込み阻害剤としての1−(2−アミノ−ベンゾール)−ピペラジン誘導体 |
PL1828154T3 (pl) * | 2004-12-09 | 2009-10-30 | Hoffmann La Roche | Pochodne fenylopiperazynometanonu |
MX2007006896A (es) * | 2004-12-15 | 2007-06-26 | Hoffmann La Roche | Fenil-metanonas bi- y triciclicas sustituidas como inhibidores del transportador 1 de glicina (glyt-1) para el tratamiento de la enfermedad de alzheimer. |
JP2009516729A (ja) * | 2005-11-23 | 2009-04-23 | アストラゼネカ アクチボラグ | L−フェニルアラニン誘導体 |
-
2005
- 2005-12-13 US US11/302,403 patent/US7485637B2/en not_active Expired - Fee Related
- 2005-12-27 ES ES05820269T patent/ES2319220T3/es active Active
- 2005-12-27 DE DE602005012997T patent/DE602005012997D1/de active Active
- 2005-12-27 CA CA002594260A patent/CA2594260A1/en not_active Abandoned
- 2005-12-27 RU RU2007124546/04A patent/RU2007124546A/ru not_active Application Discontinuation
- 2005-12-27 MX MX2007008043A patent/MX2007008043A/es active IP Right Grant
- 2005-12-27 EP EP05820269A patent/EP1836168B1/de not_active Not-in-force
- 2005-12-27 BR BRPI0519746-5A patent/BRPI0519746A2/pt not_active IP Right Cessation
- 2005-12-27 AU AU2005324109A patent/AU2005324109B2/en not_active Ceased
- 2005-12-27 JP JP2007549822A patent/JP4738421B2/ja not_active Expired - Fee Related
- 2005-12-27 CN CN2005800476568A patent/CN101111477B/zh not_active Expired - Fee Related
- 2005-12-27 WO PCT/EP2005/014052 patent/WO2006072432A1/en active Application Filing
- 2005-12-27 AT AT05820269T patent/ATE423770T1/de active
- 2005-12-27 KR KR1020077017900A patent/KR100957280B1/ko not_active IP Right Cessation
-
2006
- 2006-01-02 TW TW095100092A patent/TW200635898A/zh unknown
- 2006-01-03 AR ARP060100011A patent/AR052553A1/es unknown
-
2007
- 2007-06-25 IL IL184206A patent/IL184206A/en active IP Right Grant
- 2007-06-27 NO NO20073275A patent/NO20073275L/no not_active Application Discontinuation
- 2007-07-02 ZA ZA200705383A patent/ZA200705383B/xx unknown
Also Published As
Publication number | Publication date |
---|---|
AR052553A1 (es) | 2007-03-21 |
CA2594260A1 (en) | 2006-07-13 |
US20060148797A1 (en) | 2006-07-06 |
AU2005324109A1 (en) | 2006-07-13 |
IL184206A (en) | 2011-09-27 |
DE602005012997D1 (de) | 2009-04-09 |
NO20073275L (no) | 2007-07-31 |
TW200635898A (en) | 2006-10-16 |
CN101111477B (zh) | 2010-05-26 |
MX2007008043A (es) | 2007-07-16 |
JP4738421B2 (ja) | 2011-08-03 |
WO2006072432A1 (en) | 2006-07-13 |
AU2005324109B2 (en) | 2011-01-20 |
KR100957280B1 (ko) | 2010-05-12 |
IL184206A0 (en) | 2007-10-31 |
CN101111477A (zh) | 2008-01-23 |
RU2007124546A (ru) | 2009-02-20 |
BRPI0519746A2 (pt) | 2009-03-10 |
EP1836168B1 (de) | 2009-02-25 |
KR20070094953A (ko) | 2007-09-27 |
EP1836168A1 (de) | 2007-09-26 |
ES2319220T3 (es) | 2009-05-05 |
US7485637B2 (en) | 2009-02-03 |
ZA200705383B (en) | 2008-09-25 |
JP2008526794A (ja) | 2008-07-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NL300915I2 (nl) | Daratumumab | |
ATE400271T1 (de) | Aryl-pyridinderivate als 11-beta-hsd1-hemmer | |
ATE420076T1 (de) | Indozolonderivate als 11b-hsd1-inhibitoren | |
ATE490254T1 (de) | Imidazoä1,2-aüpyridin-verbindungen als vegf-r2- hemmer | |
CY2013047I1 (el) | Ενωσεις διαρυλυδαντοϊνης | |
ATE460417T1 (de) | Acetylenylpyrazolopyrimidinderivate als mglur2- antagonsten | |
ATE479676T1 (de) | Als antikoagulanzien verwendbare phenylglycinamid-derivate | |
DK2194043T3 (da) | Fremgangsmåder | |
ATE549333T1 (de) | Neue sulfonylpyrrole als hdac-inhibitoren | |
ATE408603T1 (de) | Pyrazolylcarboxanilide | |
CR9974A (es) | Gavión | |
ATE452132T1 (de) | Benzimidazolthiophenverbindungen als plk- inhibitoren | |
ATE549324T1 (de) | Tetrahydrobenzoxazine | |
DE112006002964A5 (de) | Zweirichtungsreflektanzverteilungsmessgerät | |
DE602005019719D1 (de) | 3-piperidinylisochroman-5-ole als dopaminagonisten | |
DE502005005839D1 (de) | Feldgeerät | |
DE602006014973D1 (de) | Neuartige cercosporamidderivate | |
DE602006007832D1 (de) | Benzotriazolderivate als cannabinoidrezeptorantagonisten | |
ATE485368T1 (de) | Hiv - impfung | |
DE102005052834B8 (de) | Punktschweißklebverbindung | |
AT501523A3 (de) | Estrich | |
ATE423770T1 (de) | Benzoyltetrahydropyridine als glyt-1-inhibitoren | |
DE102006033170A8 (de) | Einfassnähmaschine | |
AT501968A3 (de) | Mitführhilfe | |
DE502006000445D1 (de) | Mulchmähdeck |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification |
Ref document number: 1836168 Country of ref document: EP |